Page 68 - AN-3-1

Advanced Neurology Dementia with Lewy bodies and substance misuse

100. Maust DT, Lin LA, Blow FC. Benzodiazepine use and 111. Brett J, Murnion B. Management of benzodiazepine
misuse among adults in the united states. Psychiatr Serv. misuse and dependence. Aust Prescr. 2015;38(5):152-155.
2019;70(2):97-106.
doi: 10.18773/austprescr.2015.055
doi: 10.1176/appi.ps.201800321
112. Schoch P, Richards JG, Häring P, et al. Co-localization of
101. Kennedy KM, O’Riordan J. Prescribing benzodiazepines GABA receptors and benzodiazepine receptors in the brain
in general practice. Br J Gen Pract. 2019;69(680):152-153. shown by monoclonal antibodies. Nature. 1985;314:168-171.
doi: 10.3399/bjgp19X701753 doi: 10.1038/314168a0
102. Tsuda M, Shimizu N, Yajima Y, Suzuki T, Misawa M. 113. Tietz EI, Rosenberg HC, Chiu TH. Autoradiographic
Hypersusceptibility to DMCM-induced seizures during localization of benzodiazepine receptor downregulation.
diazepam withdrawal in mice: Evidence for upregulation of J Pharmacol Exp Ther. 1986;236(1):284-292.
NMDA receptors. Naunyn Schmiedebergs Arch Pharmacol.
1998;357(3):309-315. 114. Vinkers CH, Olivier B. Mechanisms underlying tolerance
after long-term benzodiazepine use: A future for subtype-
doi: 10.1007/pl00005172 selective GABAA receptor modulators? Adv Pharmacol
103. Koob GF, Le Moal M. Plasticity of reward neurocircuitry Sci. 2102;2012:416864.
and the “dark side” of drug addiction. Nat Neurosci. doi: 10.1155/2012/416864
2005;8(11):1442-1444.
115. Izzo E, Auta J, Impagnatiello F, Pesold C, Guidotti A, Costa E.
doi: 10.1038/nn1105-1442 Glutamic acid decarboxylase and glutamate receptor changes
104. Volkow ND, Koob GF, McLellan AT. Neurobiologic during tolerance and dependence to benzodiazepines. Proc
advances from the brain disease model of addiction. Natl Acad Sci U S A. 2001;98(6):3483-3488.
N Engl J Med. 2016;374(4):363-371. doi: 10.1073/pnas.051628698
doi: 10.1056/NEJMra1511480 116. Van Sickle BJ, Cox AS, Schak K, Greenfield LJ Jr.,
105. Tanaka M, Tóth F, Polyák H, et al. Immune influencers Tietz EI. Chronic benzodiazepine administration alters
in action: Metabolites and enzymes of the tryptophan- hippocampal CA1 neuron excitability: NMDA receptor
kynurenine metabolic pathway. Biomedicines. function and expression(1). Neuropharmacology.
2021;9(7):734. 2002;43(4):595-606.
doi: 10.3390/biomedicines9070734 doi: 10.1016/s0028-3908(02)00152-1
106. Britt JP, Bonci A. Optogenetic interrogations of the neural 117. Gravielle MC. Activation-induced regulation of GABAA
circuits underlying addiction. Curr Opin Neurobiol. receptors: Is there a link with the molecular basis of
2013;23(4):539-545. benzodiazepine tolerance? Pharmacol Res. 2016;109:92-100.
doi: 10.1016/j.conb.2013.01.010 doi: 10.1016/j.phrs.2015.12.030
107. Allison C, Pratt JA. Neuroadaptive processes in GABAergic 118. Tehrani MH, Barnes EM Jr. Sequestration of gamma-
and glutamatergic systems in benzodiazepine dependence. aminobutyric acid A receptors on clathrin-coated vesicles
Pharmacol Ther. 2003;98(2):171-195. during chronic benzodiazepine administration in vivo.
J Pharmacol Exp Ther. 1997;283(1):384-390.
doi: 10.1016/s0163-7258(03)00029-9
119. Bonavita C, Ferrero A, Cereseto M, et al. Adaptive changes
108. Edinoff AN, Nix CA, Hollier J, et al. Benzodiazepines: in the rat hippocampal glutamatergic neurotransmission
Uses, dangers, and clinical considerations. Neurol Int. are observed during long-term treatment with lorazepam.
2021;13(4):594-607.
Psychopharmacology (Berl). 2003;166(2):163-167.
doi: 10.3390/neurolint13040059
doi: 10.1007/s00213-002-1373-y
109. U.S. Food and Drug Administration. FDA Requiring Boxed 120. Allison C, Pratt J. Differential effects of two chronic
Warning Updated to Improve Safe Use of Benzodiazepine
Drug Class. Available from: https://www.fda.gov/drugs/ diazepam treatment regimes on withdrawal anxiety and
AMPA receptor characteristics. Neuropsychopharmacol.
drug-safety-and-availability/fda-requiring-boxed- 2006;31:602-619.
warning-updated-improve-safe-use-benzodiazepine-
drug-class [Last accessed on 2023 Oct 19]. doi: 10.1038/sj.npp.1300800
110. American Addictions Centers. 6 of the Hardest Drugs to 121. Henry ME, Jensen JE, Licata SC, et al. The acute and late CNS
Quit. Available from: https://americanaddictioncenters. glutamine response to benzodiazepine challenge: A pilot
org/adult-addiction-treatment-programs/hardest-quit pharmacokinetic study using proton magnetic resonance
[Last accessed on 2023 Oct 19]. spectroscopy. Psychiatry Res. 2010;184(3):171-176.

Volume 3 Issue 1 (2024) 16 https://doi.org/10.36922/an.2232